Pfizer Stock

Pfizer EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Pfizer (PFIZER.NS) as of Aug 3, 2026 is 31.80. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 37.82 — a change of -15.92% (lower).

EV/EBIT

31.80

YoY

-15.92%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Pfizer is 2026 31.80 . EV/EBIT (Enterprise Value to EBIT) of Pfizer was 2025 37.82 . It decreases by -15.92% lower compared to the previous year.

The Pfizer EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
35.71 base
Jan 1, 2020
48.67 base
Jan 1, 2021
37.88 base
Jan 1, 2022
27.77 base
Jan 1, 2023
27.41 base
Jan 1, 2024
41.28 base
Jan 1, 2025
32.76 base
Jan 1, 2026 (e)
28.71 base
YEARPRICE-TO-EBIT
2026 est 28.71
2025 32.76
2024 41.28
2023 27.41
2022 27.77
2021 37.88
2020 48.67
2019 35.71
2018 27.67
2017 29.73
2016 20.75
2015 37.42
2014 24.51
2013 -4.70
2012 -2.52
2011 9.36
2009 7.14
2008 -2.60
2007 6.01
2006 11.07
2005 18.95
Access this data via the Eulerpool API

Pfizer Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Pfizer's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Pfizer's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Pfizer's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Pfizer grows earnings faster than its peers.

Pfizer Stock analysis

What does Pfizer do? Pfizer Ltd is a global biopharmaceutical company based in New York City, USA. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart, and has achieved numerous milestones in the pharmaceutical industry during its 170-year history. Pfizer's business model is based on the research, development, production, and distribution of innovative drugs and vaccines for a variety of diseases. With a diverse portfolio of products, the company's range extends from drugs for cancer, inflammation, and immunology to neurological and cardiology conditions. Pfizer is a global leader in the development of cancer drugs and has achieved groundbreaking research successes in recent years. Key divisions of the company include oncology, pain management, cardiology, and neurology. Pfizer places great emphasis on putting patients and their needs at the center and works closely with medical professionals, patient groups, and authorities to ensure the best possible patient care. Pfizer is a leading provider of vaccines and has achieved significant breakthroughs in the development of COVID-19 vaccines in recent years. In December 2020, the company was one of the first worldwide to bring a vaccine against the coronavirus to market, making a significant contribution to the fight against the pandemic. In addition to drug research and development, Pfizer is also heavily involved in corporate social responsibility. The company is committed to sustainable development and continuously works to reduce its carbon footprint. The Pfizer Foundation also supports numerous nonprofit organizations and projects in the areas of health, education, and environmental protection. Among Pfizer's most well-known products are medications such as Viagra, Lipitor, and Lyrica, as well as the COVID-19 vaccine Comirnaty. Pfizer has offices in over 150 countries and employs over 90,000 people worldwide. Like any global company, Pfizer faces challenges. The company is often criticized for high drug prices and the availability of medications in developing countries. However, Pfizer actively advocates for access to affordable healthcare and delivers drugs and vaccines to all regions of the world. Overall, Pfizer is a company of great importance in the global healthcare industry. Through its research and development of innovative drugs and vaccines, the company contributes to improving the quality of life for millions of people worldwide. Pfizer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pfizer stock

EV/EBIT (Enterprise Value to EBIT) of Pfizer is 31.80 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Pfizer changed from 37.82 to 31.80, representing a -15.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Pfizer since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Pfizer with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Pfizer

All Key Metrics — Pfizer